Economic Times

Business Standard

Ø  US Federal Reserve keeps key rate unchanged 

Ø  CAD narrows to $300mn in Q1 on import contraction

Ø  Pricing of 700 MHz spectrum band expensive: Mittal

Ø  India, China may escape worst of global environment: UNCTAD

Ø  Sebi asks NSE to take stock of possible wrongdoing

Ø  Rel Defence in talks to sell vessels to Coast Guard

Ø  IOC, GAIL to take 49% stake in Adani Group's project



Ø  OECD sees globalisation brake on growth

Ø  Cabinet clears conversion of R&C loan into equity

Ø  Govt irked by Moody's statement on ratings upgrade

Ø  Sebi to auction Sahara group's 13 more land parcels

Ø  Cabinet approves closing down Hindustan Diamonds

Ø  ICICI Prudential IPO oversubscribed 10 times

Ø  Nestle seeks SC nod to destroy 550 tonnes of Maggi Noodles

Business Line

Ø  Cabinet approves Rs. 1,250 cr subsidy to BSNL

Ø  Govt extends stock limits on pulses, edible oils by one year

Ø  YES Bank invokes ₹156-crore pledged United Breweries shares

Ø  Seafood industry has a rosy future, says MPEDA chief

Ø  Steel demand likely to grow 5.3% this fiscal

Ø  Essel Propack buys out partner’s stake in JV firm 

Mint

Ø  Rupee closes little changed against US dollar

Ø  Adani unveils world’s largest solar plant in Tamil Nadu

Ø  Govt set to fund eastern gas pipeline project

Ø  Suzlon plans to raise $3 billion for Australian wind farms by 2020

Ø  Cabinet approves purchase of 36 Rafale fighter jets: report

Ø  Private equity upbeat on retail commercial space in India

Financial Express               

Ø  Markets in wait and watch mode ahead of US Fed outcome

Ø  Marine exports likely to rise 20% to $5.6 billion in 2016-17: Govt

Ø  NTPC gets shareholders' nod to raise up to Rs15k cr via bonds

Ø  Tata Communications tests UHD broadcast at Singapore F1 race

Ø  SAIL eyes sales of 14.52 MT in FY'17; production of 17.16 MT



Financial Chronicle

Ø  Cabinet approves merging of Rail budget with Union Budget

Ø  Stockholding cap on pulses, edible oils extended

Ø  BOJ rate surprise lifts world stocks ahead of Fed

Ø  Federal Reserve expected to keep rates unchanged

Ø  CIL gears up for double-digit production growth

Ø  Aurobindo Pharma, Cadila recall drugs from US market